18
FEB
2020
NW Bio Announces Annual Shareholders’ Meeting for April 18, 2020
Comments : Off
Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that the 2019 Annual Shareholder’s Meeting will be held on April 18, 2020, at 1:00 pm in Washington, DC. Read More